2020 – Page 18 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2020-08-22

An uncontrolled and placebo group lacking study on 35.000 patients suggests convalescent plasma shows a 3% reduced mortality in Covid-19 patients.

Infusing hospitalized Covid-19 patients with blood plasma from people who recovered from the disease appeared to show a benefit in a nationwide study, but the study’s lack of a placebo group left several experts struggling to interpret the data. The study, which enrolled more than 35,000 patients, found that quickly administering so-called convalescent plasma had

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-21

Study analyzes how SARS-CoV-2 undermines immune defenses

A new research study used whole-genome sequencing to analyze the genetic profile of patients with the SARS-CoV-2 virus to gain more insight into how it turns the body’s own immune system against itself. The findings could help researchers develop drugs to target the virus, according to an August 3 report in Nature Medicine. Researchers focused on

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-21

Mild coronavirus infections due to SARS-CoV-2 mutation

A mutant SARS-CoV-2 variant that has appeared in East Asia appears to cause milder infections than the form without this mutation. Overall, there are initial indications that the coronavirus could weaken. As early as January and February 2020, researchers from Singapore identified a SARS-CoV-2 variant in a cluster of Covid-19 patients that had a 382 base

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-21

Shifting public health messaging about face coverings could improve uptake

Face coverings need to be grounded in the social and cultural realities of affected communities, say researchers. Encouraging the public to see face masks as a social practice, which they can use to express their cultural background or their personality, could encourage more people to use them regularly, say researchers writing in The BMJ today. Helene-Mari van

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-21

Triad of molecules could predict severity of COVID-19

In a new study, published in Nature Medicine, researchers at the Francis Crick Institute, King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, have found a common immune signature in the blood of patients with COVID-19, which could be used to predict how severely ill a patient will become, thereby aiding patient management. The team analysed blood samples

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-20

A look at Human Cardiovascular System using EXPLORER Total-Body PET Scanner

Source NIH Watch this brief video and you might guess you’re seeing an animated line drawing, gradually revealing a delicate take on a familiar system: the internal structures of the human body. But this movie doesn’t capture the work of a talented sketch artist. It was created using the first 3D, full-body imaging device using

No Comments InRESEARCH

PIER MARIA FORNASARI
2020-08-20

Effects of COVID-19 on the nervous system: a review published on Cell

Neurological complications have emerged as a significant cause of morbidity and mortality in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized patients exhibit neurological manifestations, ranging from headache and loss of smell, to confusion and disabling strokes. COVID-19 is also anticipated to take a toll on the nervous system in the long term. In

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-20

Cytokine storm in COVID-19 patients may induce loss of transitional and follicular B cells

The release of massive amounts of proteins called cytokines can lead to some of the most severe symptoms of COVID-19. When large numbers of immune cells release cytokines, this increases inflammation and creates a feedback loop in which more immune cells are activated and this is sometimes called a cytokine storm. An August 19 study

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-17

Two existing drugs point to a potential new target against COVID-19

New lab-based studies show that two existing drugs, including one developed by a researcher at Harvard Medical School and Boston Children’s Hospital, inhibit SARS-CoV-2 — the virus that causes COVID-19 — from infecting human cells in a dish. Both drugs, vacuolin-1 and apilimod, originally developed years ago, target a large enzyme called PIKfyve kinase. Before

No Comments InCovid-19

PIER MARIA FORNASARI
2020-08-17

The six strains of SARS-CoV-2

The virus causing the COVID-19 pandemic, SARS-CoV-2, presents at least six strains. Despite its mutations, the virus shows little variability, and this is good news for the researchers working on a viable vaccine. These are the results of the most extensive study ever carried out on SARS-CoV-2 sequencing. Researchers at the University of Bologna drew

No Comments InCovid-19

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Archives: 2020-08-22

An uncontrolled and placebo group lacking study on 35.000 patients suggests convalescent plasma shows a 3% reduced mortality in Covid-19 patients.

Study analyzes how SARS-CoV-2 undermines immune defenses

Mild coronavirus infections due to SARS-CoV-2 mutation

Triad of molecules could predict severity of COVID-19

A look at Human Cardiovascular System using EXPLORER Total-Body PET Scanner

Effects of COVID-19 on the nervous system: a review published on Cell

Cytokine storm in COVID-19 patients may induce loss of transitional and follicular B cells

Two existing drugs point to a potential new target against COVID-19

The six strains of SARS-CoV-2